Suraj Kalia
Stock Analyst at Oppenheimer
(2.20)
# 2,666
Out of 4,711 analysts
82
Total ratings
38.46%
Success rate
-1.37%
Average return
Main Sectors:
Stocks Rated by Suraj Kalia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMDX TransMedics Group | Maintains: Outperform | $125 | $61.70 | +102.59% | 9 | Dec 3, 2024 | |
| AORT Artivion | Maintains: Outperform | $30 → $32 | $28.48 | +12.36% | 3 | Nov 8, 2024 | |
| LMAT LeMaitre Vascular | Reiterates: Outperform | $90 → $93 | $92.12 | +0.96% | 2 | Nov 1, 2024 | |
| ATRC AtriCure | Maintains: Outperform | $32 → $36 | $30.72 | +17.19% | 6 | Oct 30, 2024 | |
| ABT Abbott Laboratories | Initiates: Outperform | $130 | $114.23 | +13.81% | 1 | Oct 8, 2024 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $10 | $4.05 | +146.91% | 1 | Sep 16, 2024 | |
| EW Edwards Lifesciences | Maintains: Outperform | $90 | $74.81 | +20.30% | 5 | Sep 12, 2024 | |
| NYXH Nyxoah | Maintains: Outperform | $15 → $13 | $8.01 | +62.30% | 4 | Aug 7, 2024 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $165 → $145 | $90.39 | +60.42% | 4 | Aug 2, 2024 | |
| ITGR Integer Holdings | Initiates: Outperform | $135 | $133.67 | +0.99% | 1 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $237.27 | - | 6 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $3.79 | - | 8 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $30 | $14.16 | +111.86% | 5 | Nov 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $30 | $17.00 | +76.47% | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $16 → $10 | $0.40 | +2,380.77% | 1 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $97 | $78.91 | +22.92% | 1 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $27.39 | +2.23% | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $4.5 | $3.09 | +45.63% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $4.64 | +244.83% | 1 | Sep 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $524.43 | - | 3 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $60 | $0.32 | +18,493.12% | 2 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $187.77 | - | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Perform | n/a | $6.76 | - | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $29.50 | +238.98% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $80.04 | - | 5 | Sep 12, 2018 |
TransMedics Group
Dec 3, 2024
Maintains: Outperform
Price Target: $125
Current: $61.70
Upside: +102.59%
Artivion
Nov 8, 2024
Maintains: Outperform
Price Target: $30 → $32
Current: $28.48
Upside: +12.36%
LeMaitre Vascular
Nov 1, 2024
Reiterates: Outperform
Price Target: $90 → $93
Current: $92.12
Upside: +0.96%
AtriCure
Oct 30, 2024
Maintains: Outperform
Price Target: $32 → $36
Current: $30.72
Upside: +17.19%
Abbott Laboratories
Oct 8, 2024
Initiates: Outperform
Price Target: $130
Current: $114.23
Upside: +13.81%
TriSalus Life Sciences
Sep 16, 2024
Initiates: Outperform
Price Target: $10
Current: $4.05
Upside: +146.91%
Edwards Lifesciences
Sep 12, 2024
Maintains: Outperform
Price Target: $90
Current: $74.81
Upside: +20.30%
Nyxoah
Aug 7, 2024
Maintains: Outperform
Price Target: $15 → $13
Current: $8.01
Upside: +62.30%
iRhythm Technologies
Aug 2, 2024
Maintains: Outperform
Price Target: $165 → $145
Current: $90.39
Upside: +60.42%
Integer Holdings
Jul 16, 2024
Initiates: Outperform
Price Target: $135
Current: $133.67
Upside: +0.99%
Jun 25, 2024
Downgrades: Perform
Price Target: n/a
Current: $237.27
Upside: -
Feb 22, 2024
Downgrades: Perform
Price Target: n/a
Current: $3.79
Upside: -
Nov 15, 2023
Maintains: Outperform
Price Target: $42 → $30
Current: $14.16
Upside: +111.86%
Aug 8, 2023
Maintains: Outperform
Price Target: $24 → $30
Current: $17.00
Upside: +76.47%
Jun 23, 2023
Maintains: Outperform
Price Target: $16 → $10
Current: $0.40
Upside: +2,380.77%
May 16, 2023
Initiates: Outperform
Price Target: $97
Current: $78.91
Upside: +22.92%
Mar 6, 2023
Reiterates: Outperform
Price Target: $28
Current: $27.39
Upside: +2.23%
Nov 29, 2022
Initiates: Outperform
Price Target: $4.5
Current: $3.09
Upside: +45.63%
Sep 24, 2021
Initiates: Outperform
Price Target: $16
Current: $4.64
Upside: +244.83%
Apr 21, 2021
Upgrades: Perform
Price Target: n/a
Current: $524.43
Upside: -
Nov 17, 2020
Upgrades: Outperform
Price Target: $60
Current: $0.32
Upside: +18,493.12%
Nov 3, 2020
Upgrades: Perform
Price Target: n/a
Current: $187.77
Upside: -
Sep 15, 2020
Initiates: Perform
Price Target: n/a
Current: $6.76
Upside: -
Jun 24, 2020
Initiates: Outperform
Price Target: $100
Current: $29.50
Upside: +238.98%
Sep 12, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $80.04
Upside: -